Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
MedTech
Roche launches differential diagnosis test for mesothelioma
Roche announced the global launch of its VENTANA BAP1 (SP527) test, an automated, ready-to-use immunohistochemistry (IHC) assay.
Patrick McGuire
Oct 30, 2026 3:54am
After Enhertu: The slow hunt for next-gen HER2 breast cancer drugs
Oct 28, 2026 9:00am
ESMO: Roche touts ‘convincing’ KRAS data after phase 3 win
Oct 25, 2026 11:30am
Roche details ph. 3 kidney disease win amid blockbuster hopes
Oct 23, 2026 1:30pm
Roche pays Zymeworks $55M for challenger to Amgen’s Imdelltra
Oct 23, 2026 7:28am
Roche CEO has ‘absolutely not’ changed view on Poseida buyout
Oct 22, 2026 4:16am
